Ann Thorac Surg
- JEON YJ, Son JA, Lee J, Park SY, et al
Prognosis of Isolated Cervical Node Recurrence Following Esophagectomy With
Two-Field Lymphadenectomy for Esophageal Squamous Cell Carcinoma.
Ann Thorac Surg. 2026 Feb 19:S0003-4975(26)00143.
Anticancer Res
- KITASAKI N, Hamai Y, Hirohata R, Ohsawa M, et al
Prediction of Pathological Response and Prognosis After Surgery by Tumor
Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous
Cell Carcinoma.
Anticancer Res. 2026;46:1629-1638.
- TSUJI M, Kobayashi K, Kawakami K, Fukuda N, et al
Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in
Lenvatinib Therapy.
Anticancer Res. 2026;46:1651-1659.
- TAKAHASHI T, Shishido Y, Sakabe T, Orihara J, et al
Roles of GPX4 and FSP1 in Esophageal Squamous Cell Carcinoma Treated With
Neoadjuvant Chemotherapy.
Anticancer Res. 2026;46:1529-1543.
- ATHANASOPOULOS M, Papanikolaou V, Roukas D, Chrysovergis A, et al
FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell
Carcinomas.
Anticancer Res. 2026;46:1421-1428.
BMC Cancer
- SI L, Zhao C, Chard Dunmall LS, Wang P, et al
Oncolytic adenovirus type 11-induced ferroptosis of esophageal squamous cell
carcinoma cells involves in mitochondrial impairment and the mTOR pathway.
BMC Cancer. 2026 Feb 24. doi: 10.1186/s12885-026-15735.
- SHI J, Liu J, Xu Z, Chen M, et al
Association of sarcopenia with pathologic complete response in esophageal
squamous cell carcinoma patients undergoing neoadjuvant immunochemotherapy.
BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15782.
BMC Surg
- XUE M, Wu M, Lu M
Successful rescue of a patient with aortoesophageal fistula secondary to
anastomotic leak after esophagectomy.
BMC Surg. 2026;26:166.
- LI X, Zhang X, Lin Y, Ma Y, et al
Novel laryngeal preservation technique in postcricoid hypopharyngeal carcinoma: a
case-series study.
BMC Surg. 2026 Mar 4. doi: 10.1186/s12893-026-03586.
Clin Nucl Med
- DHARMASHAKTU Y, Rastogi S, Wakankar R, Shamim SA, et al
18F-FDG PET/CT Demonstrates Significant Response in Anaplastic Thyroid Carcinoma
Treated With Combined Immunotherapy and Targeted Therapy.
Clin Nucl Med. 2026 Feb 25. doi: 10.1097/RLU.0000000000006207.
Dis Esophagus
- RAYNER CJ, Paine H, Luangsomboon A, McGuire A, et al
Robotic-Assisted Ivor Lewis Esophagectomy (RAILE): a comparative analysis of a
single unit, consecutive series of Open, Hybrid, and Robotic approaches.
Dis Esophagus. 2026;39:doag016.
Head Neck
- SINGH AG, Kole L, Sullivan R, Sinha S, et al
Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy
Drugs Used in Head and Neck Cancers.
Head Neck. 2026 Feb 26. doi: 10.1002/hed.70212.
Int J Cancer
- WU H, Li Y, Ran L, Xia Z, et al
Needle-shaped diatom frustules in food as a possible promoter of esophageal
squamous cell carcinoma in coastal southeastern China: A pilot study.
Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70394.
- PENG L, Ding X, Zou RC, You R, et al
Comparison of >/=2 lines immunotherapy regimens for recurrent/metastatic
nasopharyngeal carcinoma.
Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70399.
- NETHAN ST, Perez-de-Oliveira ME, Campbell F, Santos-Silva AR, et al
Interventions for oral cancer prevention: An evidence and gap map.
Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70391.
Int J Radiat Oncol Biol Phys
- HAN JE, Diplas BH, Paudyal R, Oh JH, et al
Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive
Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human
Papillomavirus-Associated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2026;124:1015-1023.
J Laryngol Otol
- DRANOVA S
Beyond the conventional: the efficacy of liquid biopsy in post-therapeutic
monitoring of oropharyngeal cancer, a meta-analysis.
J Laryngol Otol. 2026;140:123-131.
Oral Oncol
- MARGONI A, Papavassiliou KA, Papavassiliou AG
From heterogeneity to molecular stratification: A multiplex genomic panel for
tailored therapy of head and neck squamous cell carcinoma.
Oral Oncol. 2026;175:107904.
- ECONOMOPOULOU P, Pouliakis A, Kyprianou M, Pantazopoulos A, et al
An observational retro-prospective study on patients with head and neck cancer
who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19
collabOraTion).
Oral Oncol. 2026;175:107900.
- HOLGADO A, Llansana A, Vazquez C, Gallego O, et al
Identification of prognostic variables in patients with recurrent head and neck
squamous cell carcinoma treated with salvage surgery: Implications for treatment
with immunotherapy.
Oral Oncol. 2026;175:107903.
- BHATI M, Bagchi P, Pawar P, Baviskar P, et al
Aberrant lateral position of external carotid artery, a surgical pitfall during
neck dissection.
Oral Oncol. 2026;175:107905.
- NTOUKAS SM, Mohamad N, Boparai R, Dennett L, et al
Effects of exercise on health-related fitness and patient-reported outcomes in
survivors of head and neck cancer: a systematic review and meta-analysis.
Oral Oncol. 2026;175:107902.
- ZHAO ZY, He SQ, Liu GY, Lv SH, et al
Efficacy of radiotherapy to metastatic lesion in de novo metastatic
nasopharyngeal carcinoma patients: A multicenter, propensity score matching
study.
Oral Oncol. 2026;175:107907.
- SHIMIZU T, Takahashi H, Tada H, Chikamatsu K, et al
Integrative analysis of aging-related immune parameters reveals prognostic and
immunotherapeutic implications in head and neck squamous cell carcinoma.
Oral Oncol. 2026;176:107914.
Otolaryngol Head Neck Surg
- GAO EY, See ASY, Tan BKJ, Chan SWD, et al
Tonsillar Asymmetry and Malignancy: A Meta-analysis of Diagnostic Accuracy.
Otolaryngol Head Neck Surg. 2026;174:643-654.
- CHANG KW, Peterson AM, Tharakan T, Puram SV, et al
Outcomes of Minimally Invasive Transoral Surgery in HPV-Negative Oropharyngeal
Cancer.
Otolaryngol Head Neck Surg. 2026;174:765-773.
- TUCKER A, Bollig CA
A National Analysis of Microscopic Positive Margins in Oropharyngeal Cancer
Patients Undergoing Transoral Robotic Surgery.
Otolaryngol Head Neck Surg. 2026;174:756-764.
- HATTORI T, Fujii M, Ueda T, Ishikawa A, et al
Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck
Mucosal Melanoma.
Otolaryngol Head Neck Surg. 2026;174:784-791.
- DUHON BH, Sun X, Hernandez M, Lewis CM, et al
Outcomes and Risk Factors in Oncologic Temporal Bone Surgery: A Head and
Neck-Specific NSQIP Analysis.
Otolaryngol Head Neck Surg. 2026;174:774-783.
- HACK S, Karni RJ
Ethics in Practice: Immunotherapy at End of Life in Head and Neck Cancer.
Otolaryngol Head Neck Surg. 2026 Feb 24. doi: 10.1002/ohn.70177.
PLoS One
- KUROKAWA T, Iinuma T, Ebisu H, Yanagidaira T, et al
A phase I clinical trial to evaluate the tolerability and safety of an allogeneic
iPSC-derived iNKT cell and alpha-GalCer-pulsed autologous DC combination therapy for
patients with recurrent and advanced head and neck cancer: A study protocol.
PLoS One. 2026;21:e0342387.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016